CY1117751T1 - Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου - Google Patents

Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου

Info

Publication number
CY1117751T1
CY1117751T1 CY20161100561T CY161100561T CY1117751T1 CY 1117751 T1 CY1117751 T1 CY 1117751T1 CY 20161100561 T CY20161100561 T CY 20161100561T CY 161100561 T CY161100561 T CY 161100561T CY 1117751 T1 CY1117751 T1 CY 1117751T1
Authority
CY
Cyprus
Prior art keywords
benzimidazol
virus inhibitors
synchronic
respiratory
compounds
Prior art date
Application number
CY20161100561T
Other languages
English (en)
Inventor
Ludwig Paul Cooymans
Samuël Dominique Demin
Lili Hu
Tim Hugo Maria Jonckers
Pierre Jean-Marie Bernard Raboisson
Abdellah Tahri
Sandrine Marie Helene Vendeville
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43875271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1117751(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of CY1117751T1 publication Critical patent/CY1117751T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Βενζιμιδαζόλες που έχουν ανασταλτική δράση στον αναδιπλασιασμό RSV και έχουν τον τύπο (I) προφάρμακα, Ν-οξείδια, άλατα προσθήκης, τεταρτοταγείς αμίνες, συμπλέγματα μετάλλων και στερεοχημικά ισομερείς μορφές αυτών, συνθέσεις που περιέχουν αυτές τις ενώσεις ως δραστικό συστατικό και διαδικασίες για την παρασκευή αυτών των ενώσεων και συνθέσεων.
CY20161100561T 2010-12-16 2016-06-22 Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου CY1117751T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195467 2010-12-16
PCT/EP2011/073008 WO2012080446A1 (en) 2010-12-16 2011-12-16 Benzimidazole respiratory syncytial virus inhibitors
EP11802054.4A EP2651903B1 (en) 2010-12-16 2011-12-16 Benzimidazole respiratory syncytial virus inhibitors

Publications (1)

Publication Number Publication Date
CY1117751T1 true CY1117751T1 (el) 2017-05-17

Family

ID=43875271

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100561T CY1117751T1 (el) 2010-12-16 2016-06-22 Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου

Country Status (29)

Country Link
US (1) US8865705B2 (el)
EP (1) EP2651903B1 (el)
JP (1) JP6005656B2 (el)
KR (1) KR101876240B1 (el)
CN (2) CN107417683A (el)
AR (1) AR085203A1 (el)
AU (1) AU2011343255B2 (el)
BR (1) BR112013012137A2 (el)
CA (1) CA2821999C (el)
CL (1) CL2013001713A1 (el)
CY (1) CY1117751T1 (el)
DK (1) DK2651903T3 (el)
EA (1) EA022972B1 (el)
ES (1) ES2576180T3 (el)
HK (1) HK1247616A1 (el)
HR (1) HRP20160650T1 (el)
HU (1) HUE029247T2 (el)
IL (1) IL225640A (el)
MX (1) MX340030B (el)
MY (1) MY156641A (el)
NZ (1) NZ609450A (el)
PL (1) PL2651903T3 (el)
PT (1) PT2651903E (el)
SG (1) SG190766A1 (el)
SI (1) SI2651903T1 (el)
TW (1) TWI530495B (el)
UA (1) UA112298C2 (el)
WO (1) WO2012080446A1 (el)
ZA (1) ZA201304424B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
CN104470916A (zh) * 2012-06-15 2015-03-25 爱尔兰詹森研发公司 新颖的作为呼吸道合胞病毒抗病毒剂的被苯并咪唑取代的1,3-二氢-2h-苯并咪唑-2-酮衍生物
PL2864323T3 (pl) * 2012-06-15 2017-09-29 Janssen Sciences Ireland Uc Pochodne 1,3-dihydro-2h-benzoimidazol-2-onu podstawione heterocyklami jako środki przeciwwirusowe przeciwko wirusowi syncytium nabłonka oddechowego
WO2014009302A1 (en) * 2012-07-10 2014-01-16 F. Hoffmann-La Roche Ag Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
CN104903313B (zh) 2012-10-16 2017-12-29 爱尔兰詹森科学公司 Rsv抗病毒化合物
EA026546B1 (ru) 2013-01-28 2017-04-28 Янссен Сайенсиз Айрлэнд Юси Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
WO2014184163A1 (en) 2013-05-14 2014-11-20 F. Hoffmann-La Roche Ag Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
CN105392787B (zh) * 2013-05-14 2017-11-24 豪夫迈·罗氏有限公司 用于治疗和预防呼吸道合胞病毒感染的氮杂‑氧代‑吲哚
EP3033333A1 (en) 2013-08-15 2016-06-22 F. Hoffmann-La Roche AG Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
JP6485817B2 (ja) 2013-08-21 2019-03-20 ヤンセン バイオファーマ インク. 抗ウイルス化合物
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
TWI671299B (zh) 2014-04-14 2019-09-11 愛爾蘭商健生科學愛爾蘭無限公司 作為rsv抗病毒化合物之螺脲化合物
CA2957017A1 (en) * 2014-08-05 2016-02-11 Alios Biopharma, Inc. Combination therapy for treating a paramyxovirus
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
LT3324977T (lt) 2015-07-22 2022-10-25 Enanta Pharmaceuticals, Inc. Benzodiazepino dariniai kaip rsv inhibitoriai
WO2017123884A1 (en) 2016-01-15 2017-07-20 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
EP3582784B1 (en) 2017-02-16 2022-06-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
CN111386118B (zh) 2017-09-29 2023-05-09 英安塔制药有限公司 作为rsv抑制剂的组合药物剂
CA3080138A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
CN113710276B (zh) 2019-03-18 2024-03-29 英安塔制药有限公司 苯二氮䓬衍生物作为rsv抑制剂
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
TW202115085A (zh) 2019-10-04 2021-04-16 美商安塔製藥公司 抗病毒雜環化合物
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2022010882A1 (en) 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
CA3173354A1 (en) 2021-02-26 2022-09-01 Adam SZYMANIAK Antiviral heterocyclic compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960102A1 (en) 1996-07-08 1999-12-01 Du Pont Pharmaceuticals Company AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
WO2000020400A1 (en) 1998-10-05 2000-04-13 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating hepatitis c infections
SK18942001A3 (sk) 1999-06-28 2002-10-08 Janssen Pharmaceutica N. V. Inhibítory replikácie respiračného syncytiálneho vírusu
CN1210275C (zh) 1999-06-28 2005-07-13 詹森药业有限公司 呼吸道合胞病毒复制抑制剂
AU6762400A (en) 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
WO2004043913A2 (en) 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類

Also Published As

Publication number Publication date
AU2011343255A1 (en) 2013-05-02
HRP20160650T1 (hr) 2016-07-15
WO2012080446A1 (en) 2012-06-21
AU2011343255B2 (en) 2014-12-11
ES2576180T3 (es) 2016-07-06
EP2651903B1 (en) 2016-03-23
CN103313974A (zh) 2013-09-18
IL225640A (en) 2015-02-26
DK2651903T3 (da) 2016-06-27
EA201390888A1 (ru) 2013-12-30
JP2013545785A (ja) 2013-12-26
MX340030B (es) 2016-06-21
EP2651903A1 (en) 2013-10-23
US8865705B2 (en) 2014-10-21
MY156641A (en) 2016-03-15
NZ609450A (en) 2014-10-31
KR20140025321A (ko) 2014-03-04
IL225640A0 (en) 2013-06-27
CA2821999C (en) 2019-02-26
TW201305142A (zh) 2013-02-01
UA112298C2 (uk) 2016-08-25
AR085203A1 (es) 2013-09-18
CA2821999A1 (en) 2012-06-21
BR112013012137A2 (pt) 2016-08-16
MX2013006886A (es) 2013-07-05
TWI530495B (zh) 2016-04-21
HUE029247T2 (en) 2017-02-28
KR101876240B1 (ko) 2018-08-02
PL2651903T3 (pl) 2016-10-31
US20130267508A1 (en) 2013-10-10
PT2651903E (pt) 2016-06-17
SG190766A1 (en) 2013-07-31
EA022972B1 (ru) 2016-03-31
CN107417683A (zh) 2017-12-01
CL2013001713A1 (es) 2013-10-11
HK1247616A1 (zh) 2018-09-28
JP6005656B2 (ja) 2016-10-12
SI2651903T1 (sl) 2016-07-29
ZA201304424B (en) 2014-12-23

Similar Documents

Publication Publication Date Title
CY1117751T1 (el) Αναστολεις βενζιμιδαζολης αναπνευστικου συγκυτιακου ιου
CY1117763T1 (el) Ινδολες ως αντι-ιικα μεσα αναπνευστικου συγκυτιακου ιου
CY1123810T1 (el) Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα
CY1120581T1 (el) Ενωσεις και μεθοδοι χρησης τους
CY1124726T1 (el) Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv
CY1119566T1 (el) Αντιϊικες ενωσεις rsv
CY1125329T1 (el) Αντιιικες ενωσεις πυραζολο- και τριαζολο-πυριμιδινης εναντι toy rsv
BR112015022643A2 (pt) inibidores diidro-pirrolpiridinona
BR112015032710A2 (pt) inibidores de bromodomínio
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
BR112017013491A2 (pt) compostos de pirimidina fundida para o tratamento de hiv
MX2015012005A (es) Inhibidores de bromodominio.
BR112017013440A2 (pt) compostos de isoquinolina para o tratamento de hiv
EA201490949A1 (ru) Ингибиторы киназ
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
BR112015022551A2 (pt) inibidores de amido pirrol
MX2016007346A (es) Derivados de dihidropiridinona y dihidropiridazinona utiles como inhibidores de bromodominio.
BR112015022674A2 (pt) inibidores de bromodomínio
EA201691421A1 (ru) Гетероарилы и их применение
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου